血栓塞栓症(Thromboembolism):世界の治験レビュー(2015年上半期版)

GlobalDataが発行した調査報告書(GDHC2631CTIDB)
◆英語タイトル:Thromboembolism Global Clinical Trials Review, H1, 2015
◆商品コード:GDHC2631CTIDB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2015年4月17日
◆ページ数:96
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥847,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、世界における血栓塞栓症(Thromboembolism) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - 血栓塞栓症(Thromboembolism)
  - 当レポートの概要
・血栓塞栓症(Thromboembolism):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Thromboembolism Global Clinical Trials Review, H1, 2015

Summary

GlobalData’s clinical trial report, “Thromboembolism Global Clinical Trials Review, H1, 2015″ provides data on the Thromboembolism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Thromboembolism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Thromboembolism. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Thromboembolism 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Thromboembolism to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Thromboembolism to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Thromboembolism 25
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Thromboembolism Therapeutics Clinical Trials 33
Prominent Drugs 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
C. H. Boehringer Sohn AG & Co. KG 35
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 35
Bayer AG 40
Clinical Trial Overview of Bayer AG 40
Sanofi 43
Clinical Trial Overview of Sanofi 43
GlaxoSmithKline plc 45
Clinical Trial Overview of GlaxoSmithKline plc 45
Pfizer Inc. 47
Clinical Trial Overview of Pfizer Inc. 47
Bristol-Myers Squibb Company 49
Clinical Trial Overview of Bristol-Myers Squibb Company 49
Astellas Pharma Inc. 51
Clinical Trial Overview of Astellas Pharma Inc. 51
Daiichi Sankyo Company, Limited 53
Clinical Trial Overview of Daiichi Sankyo Company, Limited 53
AstraZeneca PLC 55
Clinical Trial Overview of AstraZeneca PLC 55
Johnson & Johnson 57
Clinical Trial Overview of Johnson & Johnson 57
Clinical Trial Overview of Top Institutes / Government 58
Beijing Chao-Yang Hospital 58
Clinical Trial Overview of Beijing Chao-Yang Hospital 58
McMaster University 59
Clinical Trial Overview of McMaster University 59
Ottawa Hospital Research Institute 60
Clinical Trial Overview of Ottawa Hospital Research Institute 60
Capital District Health Authority, Canada 61
Clinical Trial Overview of Capital District Health Authority, Canada 61
Hamilton Health Sciences 62
Clinical Trial Overview of Hamilton Health Sciences 62
National Institutes of Health Clinical Center 63
Clinical Trial Overview of National Institutes of Health Clinical Center 63
Seoul National University Hospital 64
Clinical Trial Overview of Seoul National University Hospital 64
The Utrecht Institute for Pharmaceutical Sciences 65
Clinical Trial Overview of The Utrecht Institute for Pharmaceutical Sciences 65
Universita degli Studi dell’Insubria 66
Clinical Trial Overview of Universita degli Studi dell’Insubria 66
Five Key Clinical Profiles 67
Appendix 94
Abbreviations 94
Definitions 94
Research Methodology 95
Secondary Research 95
About GlobalData 96
Contact Us 96
Disclaimer 96
Source 96

List of Tables
Thromboembolism Therapeutics, Global, Clinical Trials by Region, 2015* 7
Thromboembolism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Thromboembolism Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Thromboembolism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Thromboembolism Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Thromboembolism Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Thromboembolism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Thromboembolism Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Thromboembolism to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 15
Thromboembolism Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Thromboembolism Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Thromboembolism to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 18
Thromboembolism Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Thromboembolism Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Thromboembolism Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Thromboembolism Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Thromboembolism Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Thromboembolism Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Thromboembolism Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Thromboembolism Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Thromboembolism Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Thromboembolism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30
Thromboembolism Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 31
Thromboembolism Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32
Thromboembolism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33
Thromboembolism Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2015* 35
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 40
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 43
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 45
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 47
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015* 49
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015* 51
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015* 53
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 55
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 57
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Beijing Chao-Yang Hospital, 2015* 58
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by McMaster University, 2015* 59
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2015* 60
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital District Health Authority, Canada, 2015* 61
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamilton Health Sciences, 2015* 62
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institutes of Health Clinical Center, 2015* 63
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015* 64
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by The Utrecht Institute for Pharmaceutical Sciences, 2015* 65
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Universita degli Studi dell'Insubria, 2015* 66

List of Figures
Thromboembolism Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Thromboembolism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Thromboembolism Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Thromboembolism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Thromboembolism Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Thromboembolism Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Thromboembolism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Thromboembolism Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Thromboembolism to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 15
Thromboembolism Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Thromboembolism Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Thromboembolism to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 18
Thromboembolism Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Thromboembolism Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Thromboembolism Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Thromboembolism Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Thromboembolism Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Thromboembolism Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Thromboembolism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30
Thromboembolism Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 31
Thromboembolism Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32
Thromboembolism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33
Thromboembolism Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34
GlobalData Methodology 95

【レポートのキーワード】

血栓塞栓症(Thromboembolism)、治験、臨床試験、治験、治療薬

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 血栓塞栓症(Thromboembolism):世界の治験レビュー(2015年上半期版)(Thromboembolism Global Clinical Trials Review, H1, 2015)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆